Stocks
H Lundbeck A/S Sponsored ADRHLUUY
HealthcarePharmaceuticals
A Danish pharmaceutical company focused on brain diseases, including depression, schizophrenia, and Alzheimer's disease. Its portfolio includes branded therapies and a pipeline of central nervous system treatments. Investors track the ADR for exposure to the European CNS drug market and its late-stage clinical programs.
Congressional Interest in H Lundbeck A/S Sponsored ADR (HLUUY)
1 member of Congress has disclosed 1 trade in H Lundbeck A/S Sponsored ADR (HLUUY), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading HLUUY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-12-21 | Greg Gianforte | buy | $1K-$15K |